Animal Parasiticides Market by Product (Endoparasiticides, Ectoparasiticides, Endectocides, Oral Liquids, Tablets, Injectables, Sprays, Pour On, Spot On, Collars, Ear Tags), Animal (Dogs, Cats, Cattle, Pigs, Sheep & Goats) – Global Forecast to 2018

Publisher Name :
Date: 1-May-2014
No. of pages: 306
Inquire Before Buying

The veterinary pharmaceuticals including parasiticides have transformed the health of companion and livestock animals across the globe in the past two decades. Today, the spectrum of parasiticides for the veterinary applications continues to expand with variety of ectoparasiticides, endoparasiticides, and endectocides being launched every year. The innovations are leading to emergence of novel parasiticide delivery systems as well. Protection of animals from parasitic infestations has also gained greater importance in animal parasiticides market over the years.

In this report, the global animal parasiticides market is broadly segmented by product type, animal type, and geography. By product type, the animal parasiticides are classified into three major segments, namely, endoparasiticides, ectoparasiticides, and endectocides. These product segments are further sub-segmented depending on the formulation type. The endoparasiticides are classified into feed additives, injectables, oral liquids, tablets (oral solids), and other. The ectoprasiticides are classified into dips, sprays, pour on/spot on, collar, ear tags and others. On the basis of animals, animal parasiticides market is segmented into two major categories as companion animals and food producing animals. These major animal segments are further subdivided into different animal types. Companion animals include dogs, cats, horses and other companion animals while food producing animals include poultry, pigs, cattle, sheep and goats, and other food producing animals. The market is divided into North America, Europe, Asia-Pacific, and the Rest of World (RoW), based on geography.

Over the past few years, the animal parasiticides market has witnessed a stable growth. The market is expected to grow at a CAGR of 5.4% from 2013 to 2018 to reach $8,464.6 million by 2018. The overall growth in the animal parasiticides market is largely driven by rising concerns regarding zoonotic diseases; an upsurge in the investment from government organizations, non-government agencies, and leading market players; increasing demand for animal protein and animal-based food, especially in the emerging markets in APAC and Latin American region; implementation of animal welfare acts in developed countries; availability of new broad spectrum parasiticides product offerings from leading players; and an upsurge in the adoption of pet animals. However, stringent regulations for registration and approval of animal parasiticides, restrictions on the use of parasiticides in food producing animals, expensive and time consuming R&D activities to develop a new product, restriction on the use of specific parasiticides in certain countries, emerging species of parasites with resistance to existing parasiticidal agents restrict the growth of the market to a certain extent.

During the forecast period the pour-ons and spot-ons will continue to drive and dominate the animal parasiticides market. A majority share of this growth can be attributed to widening applications of ectoparasiticides for livestock animals. Furthermore, rising demand for pour-ons and spot-ons for companion animals in developed countries is also expected to drive the growth of the animal parasiticides market. Highly organized livestock farms, increased awareness towards prevention of parasitic diseases in livestock animals in order to meet the increased demand for meat and dairy products, and increasing number of farm animals is expected to fuel the demand for pour-ons and spot-ons during the forecast period of 2013-2018.

By 2018, Europe will continue to drive and dominate the animal parasiticides market, followed by North America, RoW, and Asia-Pacific. However, the market share of this region will decrease slightly during 2013 to 2018, primarily due to the increase in demand for parasiticides in the Asia-Pacific and Latin American countries. Majority of the growth in these regions is primarily driven by the increasing demand of preventive measures of parasiticide inestations in the animal health industry in China, India, and Brazil. The growth in the Asia-Pacific and Latin American regions can be attributed to the increased disposable incomes leading to growth in the per capita animal health expenditure in these regions.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering greater market shares. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.

The report provides insights on the following pointers:

  • •Market Penetration: Comprehensive information on product portfolios offered by the top players in the animal parasiticides market. The report analyzes the animal parasiticides market by product type and by animal type across all geographies
  • Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the animal parasiticides market
  • Market Development: Comprehensive information about the lucrative emerging markets by product, animal, and geography
  • Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the animal parasiticides market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analyses of the leading players in the animal parasiticides market

Animal Parasiticides Market by Product (Endoparasiticides, Ectoparasiticides, Endectocides, Oral Liquids, Tablets, Injectables, Sprays, Pour On, Spot On, Collars, Ear Tags), Animal (Dogs, Cats, Cattle, Pigs, Sheep & Goats) – Global Forecast to 2018

Table Of Contents

1 Introduction
1.1 Objectives Of The Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1Market Size Estimation
1.5.2 Market Crackdown & Data Triangulation
1.5.3 Market Share Estimation
1.5.4 Key Data From Secondary Sources
1.5.5 Key Data Points From Primary Sources
1.5.6 Assumptions

2 Executive Summary

3 Market Overview
3.1 Introduction
3.2 Market Segmentation
3.3 Market Dynamics
3.3.1 Key Market Drivers
3.3.1.1 Growing Concerns Regarding Zoonotic Diseases
3.3.1.2 Growing Investment From Government Organizations, Non-Government Agencies, And Leading Market Players
3.3.1.3 Growing Demand For Animal Protein And Animal-Based Food To Drive The Need To Keep Animals Healthy
3.3.1.4 Worldwide Regulations For Prevention Of The Spread Of Animal Diseases
3.3.2 Key Market Restraints
3.3.2.1 Shift To Vegetarian Diet Challenging The Market Growth
3.3.2.2 A Vast Diversity Of Parasites Species
3.3.2.3 Restrictions On The Use Of Endoparasiticides In Food Producing Animals
3.3.2.4 Difficulties In Approval Of Animal Parasiticides
3.3.3 Key Market Opportunities
3.3.3.1 Growing Awareness About Animal Health In Emerging Markets
3.3.3.2 Untapped Market Potential In Rural Areas In Developing Countries
3.3.4 Key Market Trends
3.3.4.1 Growing R&D Investments In The Animal Pharmaceuticals Market
3.3.4.2 Mergers And Acquisitions Among Key Market Players In The Animal Healthcare Market
3.3.4.3 Innovations In Parasiticide Product Offerings To Boost The Market
3.4 Market Share Analysis

4 Global Animal Parasiticides Market, By Product Type
4.1 Introduction
4.2 Endoparasiticide
4.2.1 Feed Additives
4.2.2 Injectables
4.2.3 Oral Liquids
4.2.4 Oral Solids (Tablets, Pills, And Granules)
4.2.5 Other Endoparasiticides
4.3 Ectoparasiticide
4.3.1 Dips
4.3.2 Sprays
4.3.3 Pour-On And Spot-On
4.3.4 Collars
4.3.5 Ear Tags
4.3.6 Others Ectoparasiticides
4.4 Endectocide

5 Global Animal Parasiticides Market, By Type Of Animal
5.1 Introduction
5.2 Companion Animals
5.2.1 Dogs
5.2.2 Cats
5.2.3 Horses
5.2.4 Other Companion Animals
5.3 Food-Producing Animals
5.3.1 Poultry
5.3.2 Cattle
5.3.3 Pigs (Swine)
5.3.4 Sheep & Goats
5.3.5 Other Food-Producing Animals

6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 U.S.
6.2.2 Canada
6.3 Europe
6.3.1 U.K.
6.3.2 Italy
6.3.3 Spain
6.3.4 France
6.3.5 Germany
6.3.6 Rest Of Europe
6.4 Asia-Pacific
6.4.1 China
6.4.2 Japan
6.4.3 India
6.4.4 Rest Of Apac
6.5 Rest Of The World
6.5.1 Latin America
6.5.2 Middle East And Africa

7 Competitive Landscape
7.1 Introduction
7.2 Acquisitions
7.3 Agreements
7.4 New Product Launches
7.5 Expansions
7.6 Others

8 Company Profiles
8.1 Bayer Ag
8.1.1 Business Overview
8.1.2 Products
8.1.3 Key Financials
8.1.4 Growth Strategy
8.1.5 Recent Developments
8.1.6 Swot Analysis
8.1.7 Mnm View
8.2 Boehringer Ingelheim
8.2.1 Business Overview
8.2.2 Products
8.2.3 Key Financials
8.2.4 Growth Strategy
8.2.5 Recent Developments
8.3 Ceva Sante Animale
8.3.1 Business Overview
8.3.2 Products
8.3.3 Key Financials
8.3.4 Growth Strategy
8.3.5 Recent Developments
8.4 Eli Lilly And Company
8.4.1 Business Overview
8.4.2 Products
8.4.3 Key Financials
8.4.4 Growth Strategy
8.4.5 Recent Developments
8.4.6 Swot Analysis
8.4.7 Mnm View
8.5 Merck & Co., Inc.
8.5.1 Business Overview
8.5.2 Products
8.5.3 Key Financials
8.5.4 Growth Strategy
8.5.5 Recent Developments
8.5.6 Swot Analysis
8.5.7 Mnm View
8.6 Novartis Ag
8.6.1 Business Overview
8.6.2 Products
8.6.3 Key Financials
8.6.4 Growth Strategy
8.6.5 Recent Developments
8.6.6 Swot Analysis
8.6.7 Mnm View
8.7 Sanofi
8.7.1 Business Overview
8.7.2 Products
8.7.3 Key Financials
8.7.4 Growth Strategy
8.7.5 Recent Developments
8.7.6 Swot Analysis
8.7.7 Mnm View
8.8 Vetoquinol
8.8.1 Business Overview
8.8.2 Products
8.8.3 Key Financials
8.8.4 Growth Strategy
8.8.5 Recent Developments
8.9 Virbac Sa
8.9.1 Business Overview
8.9.2 Products
8.9.3 Key Financials
8.9.4 Growth Strategy
8.9.5 Recent Developments
8.10 Zoetis, Inc.
8.10.1 Business Overview
8.10.2 Products
8.10.3 Key Financials
8.10.4 Growth Strategy
8.10.5 Recent Developments
8.10.6 Swot Analysis
8.10.7 Mnm View

Appendix

List Of Tables

Table 1 Global Animal Parasiticides Market, By Product Type, 2011-2018 ($Million)
Table 2 Global Animal Parasiticides Market, By Geography, 2011-2018 ($Million)
Table 3 Global Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 4 Global Animal Endoparasiticides Market, By Geography, 2011-2018 ($Million)
Table 5 Global Feed Additive Animal Endoparasiticides Market, By Geography, 2011-2018 ($Million)
Table 6 Global Injectables Animal Endoparasiticides Market, By Georgaphy, 2011-2018 ($Million)
Table 7 Global Oral Liquids Animal Endoparasiticides Market, By Geography, 2011-2018 ($Million)
Table 8 Global Oral Solids Animal Endoparasiticides Market, By Geography, 2011-2018 ($Million)
Table 9 Global Other Animal Endoparasiticides Market, By Geography, 2011-2018 ($Million)
Table 10 Global Animal Ectoparasiticides Market, By Product Type, 2011-2018 ($Million)
Table 11 Global Animal Ectoparasiticides Market, By Geography, 2011-2018 ($Million)
Table 12 Global Dips Animal Ectoparasiticides Market, By Geography, 2011-2018 ($Million)
Table 13 Global Sprays Animal Ectoparasiticides Market, By Geography, 2011-2018 ($Million)
Table 14 Global Pour-On And Spot-On Animal Ectoparasiticides Market, By Geography, 2011-2018 ($Million)
Table 15 Global Collars Animal Ectoparasiticides Market, By Geography, 2011-2018 ($Million)
Table 16 Global Ear Tags Animal Ectoparasiticides Market, By Geography, 2011-2018 ($Million)
Table 17 Global Other Animal Ectoparasiticides Market, By Geography, 2011-2018 ($Million)
Table 18 Global Animal Endectocides Market, By Geography, 2011-2018 ($Million)
Table 19 Global Animal Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 20 Global Parasiticides Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
Table 21 Global Parasiticides Market For Companion Animals, By Country, 2011-2018 ($Million)
Table 22 Global Parasiticides Market For Dogs, By Country, 2011-2018 ($Million) Table 23 Global Parasiticides Market For Cats, By Country, 2011-2018 ($Million)
Table 24 Global Parasiticides Market For Horses, By Country, 2011-2018 ($Million)
Table 25 Global Parasiticides Market For Other Companion Animals, By Country, 2011-2018 ($Million)
Table 26 Global Parasiticides Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million)
Table 27 Global Parasiticides Market For Food-Producing Animals, By Country, 2011-2018 ($Million)
Table 28 Global Parasiticides Market For Poultry, By Country, 2011-2018 ($Million)
Table 29 Global Parasiticides Market For Cattle, By Country, 2011-2018 ($Million)
Table 30 Global Parasiticides Market For Pigs, By Country, 2011-2018 ($Million)
Table 31 Global Parasiticides Market For Sheep & Goats, By Country, 2011-2018 ($Million)
Table 32 Global Parasiticides Market For Other Food-Producing Animals,By Country, 2011-2018 ($Million)
Table 33 Global Animal Parasiticides Market, By Geography, 2011-2018 ($Million)
Table 34 North America: Animal Parasiticides Market, By Country, 2011-2018 ($Million)
Table 35 North America: Animal Parasiticides Market, By Type Of Products, 2011-2018 ($Million)
Table 36 North America: Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 37 North America: Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 38 North America: Animal Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 39 North America: Animal Parasiticides Market For Food Producing Animals, By Type Of Animal, 2011-2018 ($Million)
Table 40 North America: Animal Parasiticides Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
Table 41 U.S.: Animal Parasiticides Market, By Type Of Products, 2011-2018 ($Million)
Table 42 U.S.: Animal Parasiticides Market, By Type Of Ectoparasiticides, 2011-2018 ($Million)
Table 43 U.S.: Animal Parasiticides Market, By Type Of Endoparasiticides, 2011-2018 ($Million)
Table 44 U.S.: Animal Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 45 U.S.: Animal Parasiticides Market For Food Producing Animals, By Type Of Animal, 2011-2018 ($Million)
Table 46 U.S.: Animal Parasiticides Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
Table 47 Canada: Animal Parasiticides Market, By Type Of Products, 2011-2018 ($Million)
Table 48 Canada: Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 49 Canada: Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 50 Canada: Animal Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 51 Canada: Market For Food Producing Animals, By Type Of Animal, 2011-2018 ($Million)
Table 52 Canada: Market For Companion Animals,By Type Of Animal, 2011-2018 ($Million)
Table 53 Europe: Animal Parasiticides Market, By Country, 2011-2018 ($Million)
Table 54 Europe: Market, By Product Type, 2011-2018 ($Million)
Table 55 Europe: Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 56 Europe: Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 57 Europe: Animal Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 58 Europe: Veterinary Parasiticides Market, By Type Of Food Producing Animal, 2011-2018 ($Million)
Table 59 Europe: Animal Parasiticides Market, By Type Of Companion Animal, 2011-2018 ($Million)
Table 60 U.K.: Animal Parasiticides Market, By Product Type, 2011-2018 ($Million)
Table 61 U.K.: Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 62 U.K.: Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 63 U.K.: Veterinary Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 64 U.K.: Market, By Type Of Food Producing Animals, 2011-2018 ($Million)
Table 65 U.K.:Market, By Type Of Companion Animal, 2011-2018 ($Million)
Table 66 Italy: Animal Parasiticides Market, By Product Type, 2011-2018 ($Million)
Table 67 Italy: Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 68 Italy: Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 69 Italy: Veterinary Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 70 Italy: Veterinary Parasiticides Market, By Type Of Food Producing Animals, 2011-2018 ($Million)
Table 71 Italy: Market, By Type Of Companion Animal, 2011-2018 ($Million)
Table 72 Spain: Animal Parasiticides Market, By Product Type, 2011-2018 ($Million)
Table 73 Spain: Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 74 Spain: Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 75 Spain: Veterinary Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 76 Spain: Market, By Type Of Food Producing Animals, 2011-2018 ($Million)
Table 77 Spain: Market, By Type Of Companion Animal, 2011-2018 ($Million)
Table 78 France: Animal Parasiticides Market, By Product Type, 2011-2018 ($Million)
Table 79 France: Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 80 France: Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 81 France: Veterinary Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 82 France: Market, By Type Of Food Producing Animals, 2011-2018 ($Million)
Table 83 France: Market, By Type Of Companion Animal, 2011-2018 ($Million)
Table 84 Germany: Animal Parasiticides Market, By Product Type, 2011-2018 ($Million)
Table 85 Germany: Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 86 Germany: Animal Endoparasiticides Market, By Product Type, 2011-2018 ($Million)
Table 87 Germany: Veterinary Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 88 Germany: Market, By Type Of Food Producing Animals, 2011-2018 ($Million)
Table 89 Germany: Animal Parasiticides Market, By Type Of Companion Animal, 2011-2018 ($Million)
Table 90 Rest Of Europe: Animal Parasiticides Market, By Product Type, 2011-2018 ($Million)
Table 91 Rest Of Europe: Animal Ectoparasiticides Market, By Product Type, 2011-2018 ($Million)
Table 92 Rest Of Europe: Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 93 Rest Of Europe: Veterinary Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 94 Rest Of Europe: Market, By Type Of Food Producing Animals, 2011-2018 ($Million)
Table 95 Rest Of Europe: Market, By Type Of Companion Animal, 2011-2018 ($Million)
Table 96 Apac: Animal Parasiticides Market, By Country, 2011-2018 ($Million)
Table 97 Apac: Market, By Type Of Product, 2011-2018 ($Million)
Table 98 Apac: Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 99 Apac: Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 100 Apac: Veterinary Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 101 Apac: Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million)
Table 102 Apac: Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
Table 103 China: Animal Parasiticides Market, By Type Of Product, 2011-2018 ($Million)
Table 104 China: Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 105 China: Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 106 China: Animal Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 107 China: Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million))
Table 108 China: Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
Table 109 Japan : Animal Parasiticides Market, By Type Of Product, 2011-2018 ($Million)
Table 110 Japan : Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 111 Japan : Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 112 Japan: Animal Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 113 Japan: Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million)
Table 114 Japan: Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
Table 115 India: Animal Parasiticides Market, By Type Of Product, 2011-2018 ($Million)
Table 116 India: Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 117 India: Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 118 India: Animal Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 119 India: Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million)
Table 120 India: Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
Table 121 Rest Of Apac: Animal Parasiticides Market, By Type Of Product, 2011-2018 ($Million)
Table 122 Rest Of Apac: Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 123 Rest Of Apac: Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 124 Rest Of Apac: Animal Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 125 Rest Of Apac: Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million)
Table 126 Rest Of Apac: Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
Table 127 Rest Of The World: Animal Parasiticides Market, By Region, 2011-2018 ($Million)
Table 128 Rest Of The World: Veterinary Parasiticides Market, By Product Type, 2011-2018 ($Million)
Table 129 Rest Of The World: Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 130 Rest Of The World: Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 131 Rest Of The World: Veterinary Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 132 Rest Of The World: Market, By Type Of Food Producing Animals, 2011-2018 ($Million)
Table 133 Rest Of The World: Market, By Type Of Companion Animal, 2011-2018 ($Million)
Table 134 Latin America: Animal Parasiticides Market,By Product Type, 2011-2018 ($Million)
Table 135 Latin America: Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 136 Latin America: Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 137 Latin America: Animal Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 138 Latin America: Market, By Type Of Food Producing Animals, 2011-2018 ($Million)
Table 139 Latin America: Market, By Type Of Companion Animal, 2011-2018 ($Million)
Table 140 Middle East And Africa: Animal Parasiticides Market, By Product Type, 2011-2018 ($Million)
Table 141 Middle East And Africa: Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 142 Middle East And Africa: Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 143 Middle East And Africa: Animal Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 144 Middle East And Africa: Animal Parasiticides Market, By Type Of Food Producing Animals, 2011-2018 ($Million)
Table 145 Middle East And Africa: Market, By Type Of Companion Animal, 2011-2018 ($Million)
Table 146 Key Growth Strategies, 2011 - 2014
Table 147 Mergers & Acquisition, 2012-2014
Table 148 Agreements, 2012-2014
Table 149 New Product Launches, 2012-2014
Table 150 Expansions, 2011-2013
Table 151 Other Developments, 2013-2014

List Of Figures

Figure 1 Research Methodology
Figure 2 Market Size Estimation Methodology
Figure 3 Data Triangulation Methodology
Figure 4 Global Animal Parasiticides Market, By Product Type ($Million)
Figure 5 Global Animal Parasiticides Market, By Animal Type ($Million)
Figure 6 High-Growth Markets, 2013
Figure 7 Market Segmentation
Figure 8 Global Animal Parasiticides Market Dynamics
Figure 9 Global Animal Parasiticides Market Share Analysis, 2013
Figure 10 Key Growth Strategies, 2011-2014
Figure 11 Bayer Ag: Revenue Segmentation, 2013
Figure 12 Bayer Consumer Health: Total Revenue ($Million), 2011-2013
Figure 13 Bayer Consumer Health: Revenue, By Business, 2013
Figure 14 Bayer Consumer Health: Revenue, By Geography, 2013
Figure 15 Boehringer Ingelheim: Total Revenue ($Million), 2011-2013
Figure 16 Boehringer Ingelheim: Revenue, By Business, 2012
Figure 17 Boehringer Ingelheim: Animal Health Business Revenue, By Geography, 2012
Figure 18 Ceva Sante Animale: Total Revenue ($Million), 2010-2012
Figure 19 Ceva Sante Animale: Revenue, By Geography, 2012
Figure 20 Eli Lilly And Company: Animal Health Business (Elanco)Revenue ($Million), 2011-2013
Figure 21 Eli Lilly And Company: Revenue, By Business, 2013
Figure 22 Elanco: Revenue, By Geography, 2013
Figure 23 Merck & Co., Inc.: Total Revenue ($Million), 2011-2013
Figure 24 Merck And Co., Inc.: Revenue, By Business, 2013
Figure 25 Merck And Co., Inc.: Revenue, By Geography, 2013
Figure 26 Novartis Ag: Revenue Segmentation, 2013
Figure 27 Novartis Consumer Health: Total Revenue ($Million), 2011-2013
Figure 28 Novartis Ag: Revenue, By Business, 2013
Figure 29 Novartis Consumer Health: Revenue, By Geography, 2013
Figure 30 Sanofi: Revenue Segmentation, 2013
Figure 31 Merial: Total Revenue ($Million), 2011-2013
Figure 32 Merial: Revenue, By Business, 2013
Figure 33 Merial: Revenue, By Geography, 2013
Figure 34 Vetoquinol: Total Revenue ($Million),2011-2013
Figure 35 Vetoquinol: Business Revenue, By Geography, 2013
Figure 36 Virbac Sa: Total Revenue ($Million), 2010-2012
Figure 37 Virbac Sa: Revenue, By Business, 2012
Figure 38 Virbac: Business Revenue, By Geography, 2012
Figure 39 Zoetis, Inc.: Total Revenue ($Million), 2011-2013
Figure 40 Zoetis, Inc.: Revenue, By Business, 2013
Figure 41 Zoetis, Inc.: Revenue, By Geography, 2013

  • Global Stem Cell Therapy Industry Witnesses Steady Growth
    Stem cell research which is one of the most contemporary areas of biology has developed rapidly in the last couple of years. Increased funding in stem cell research by both government and private organizations is one of the main drivers in the stem cell therapy industry. Stem cells are used in various medical therapies such [...]
  • Global Lubricant Market Driven by Increased Demand in Automotive Industry
    With growth in the automobile industry, the demand for lubricants has also increased. The robust growth in manufacturing with increase in industrial production, particularly in countries such as China and India are also fueling the demand for lubricants. In 2013, the global market for lubricants had reached a value of 123.64 billion USD. By 2020, [...]
  • Global Cybersecurity Market Driven by Increase in Cyber Attacks
    In recent years, the global market for cybersecurity has grown steadily, with the rapid adoption of cloud-based services. As more and more corporate and government organizations are realizing the importance of protecting data and intellectual property, the market for cybersecurity is going to expand. In 2014, the global market for cybersecurity was valued at 95.60 [...]
  • Global Epilepsy Drug Market Continues to Grow Steadily
    The global epilepsy drug market has grown steadily in recent years with increased sales of anti-epileptic drugs which are targeted at reducing seizures. Epilepsy is a condition which affects the brain and is characterized with repeated seizures in the patient. Treatment for epilepsy usually involves the use of medicines known as anti-epileptic drugs which prevents [...]
  • Global Meat and Poultry Product Market to Witness Steady Growth
    As global demand for meat and poultry products continues to rise, the market for meat and poultry is also expected to grow steadily. The market for meat and poultry products is driven by rise in disposable income, growing awareness among consumers about the importance of adding protein to their diet, and change in eating habits. [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Jordan Pharmaceuticals and Healthcare Report Q1 2015
    Published: 19-Nov-2014        Price: US $1295 Onwards        Pages: 110
    BMI View: Continuing political instability in the region is having a detrimental impact on the country's economy and healthcare sector which is burdened with many Syrian refugees. The Jordanian government is continuing to invest in the country's healthcare sector through training more staff and developing additional infrastructure. This will expand access to health services among the population and provide opportunities for drugmakers looking to enter the Jordanian pharmaceutical market. Headlin......
  • Latvia Pharmaceuticals and Healthcare Report Q1 2015
    Published: 19-Nov-2014        Price: US $1295 Onwards        Pages: 110
    BMI View: Market growth forecasts are strong although the country will continue to present a modest opportunity to larger multinational companies on account of its relatively small market size. Meanwhile, tensions between Ukraine and Russia may provide challenges for local manufacturers that had sought exports to Russia and the Commonwealth of Independent States (CIS) region as a remedy for lacklustre domestic demand in recent years. Headline Expenditure Projections ? Pharmaceuticals: EUR325mn (......
  • Romania Pharmaceuticals and Healthcare Report Q1 2015
    Published: 19-Nov-2014        Price: US $1295 Onwards        Pages: 111
    BMI View: Romania's claw back tax is likely to see a revision as domestic companies lobby to push the burden further onto innovative drugmakers. With an improving macroeconomic outlook, increased government spending is on the horizon, and that will undoubtedly benefit the pharmaceutical sector. However, stalling Eurozone growth could worsen dynamics within Romania. Headline Expenditure Projections ? Pharmaceuticals: RON13.96bn (USD4.17bn) in 2013 to RON14.65bn (USD4.38bn) in 2014; +5.0% in local......
  • Tanzania Pharmaceuticals and Healthcare Report Q1 2015
    Published: 19-Nov-2014        Price: US $1295 Onwards        Pages: 73
    BMI View: We expect the continuing depreciation of the Tanzanian shilling to make imports of raw materials increasingly expensive for the few remaining domestic pharmaceutical manufacturers. A tax regime that favours imports of finished pharmaceuticals and a lack of skilled labour will be detrimental to local manufacturers, and will see the country remain reliant on imported pharmaceuticals for the foreseeable future. Headline Expenditure Projections ? Pharmaceuticals: TZS693.86bn (USD429mn) in ......
  • Algeria Pharmaceuticals and Healthcare Report Q1 2015
    Published: 19-Nov-2014        Price: US $1295 Onwards        Pages: 103
    BMI View: Against a backdrop of economic growth, the Algerian government commitment to expand and upgrade medical coverage and healthcare services in Algeria will translate in growing commercial opportunities for pharmaceutical and healthcare industries over the medium term. Also, the government's new five-year investment plan to be implemented in 2015-2019 will focus on diversifying the economy through the promotion of industrial development, including the pharmaceutical industry. In line with ......
  • Angola Pharmaceuticals and Healthcare Report Q1 2015
    Published: 19-Nov-2014        Price: US $1295 Onwards        Pages: 60
    BMI View: The Angolan government's initiatives to make healthcare more affordable, coupled with the municipalisation of health services, will lead to greater access to medical services and increase pharmaceutical spending in Angola. A new medicine depot is a step in the right direction towards improving the traditionally difficult operating environment of the country's pharmaceutical and healthcare markets. However, poor patent protection, a lack of hospitals and clinics, and the threat of count......
  • Bulgaria Pharmaceuticals and Healthcare Report Q1 2015
    Published: 19-Nov-2014        Price: US $1295 Onwards        Pages: 103
    BMI View: Large order increases from within the hospital sector and robust consumer demand will spur pharmaceutical sales growth in 2014 and 2015. However, external slowdown will begin to impact the Bulgarian market from 2015 onwards. Bulgaria's healthcare system will continue to face issues around its funding. Headline Expenditure Projections ? Pharmaceuticals: BGN2.32bn (USD1.58bn) in 2013 to BGN2.44bn (USD1.67bn) in 2014; +5.0% in local currency terms and 5.7% in US dollar terms. US dollar fo......
  • Cote d’Ivoire Pharmaceuticals and Healthcare Report Q1 2015
    Published: 19-Nov-2014        Price: US $1295 Onwards        Pages: 59
    BMI View: Côte d'Ivoire's healthcare sector will continue to be underfunded, making it difficult for the country to achieve its healthcare-related millennium development goals. This poses questions regarding the population's access to treatment of infectious and chronic diseases. While the planned implementation of universal healthcare coverage in 2015 will increase access to healthcare services, therefore providing drugmakers with increased revenue-earning opportunities, we believe a continued......
  • Hungary Pharmaceuticals and Healthcare Report Q1 2015
    Published: 19-Nov-2014        Price: US $1295 Onwards        Pages: 104
    BMI View: We expect the decline in Hungary's pharmaceutical market to stabilise in 2015, although a challenging operating environment and regulatory burden will weigh on market growth. Our country risk team also sees potential headwinds to spending growth, namely Hungary's excessive government deficits and a German economic slowdown that will reverberate throughout the Central and Eastern European region. Pricing pressures and slow uptake of new medicines will continue to present near-term headw......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs